How Blood Cancer Develops
Blood cancer starts when cells in your bone marrow or blood begin to grow abnormally and multiply out of control. Unlike solid tumors, blood cancers don't form a single mass—instead, the abnormal cells circulate through your bloodstream or accumulate in your lymph nodes and organs. The three main types are leukemia (cancer of white blood cells), lymphoma (cancer of lymph tissue), and myeloma (cancer of plasma cells). Each develops differently, but all involve a breakdown in the normal process that controls how blood cells divide and die.
Your bone marrow produces blood cells at a carefully regulated pace. Normally, old cells die and are replaced by new ones in a balanced cycle. In blood cancer, this cycle breaks down. A single cell acquires genetic mutations that allow it to divide repeatedly without stopping, and its descendants inherit those same mutations. Over time, these abnormal cells outnumber healthy ones, crowding them out and preventing your blood from working properly.
Key Takeaways
- Blood cancer occurs when bone marrow cells acquire genetic mutations that cause them to divide uncontrollably and accumulate in the blood, bone marrow, or lymph nodes.
- Most blood cancers develop from a combination of factors—age, inherited genetic conditions, prior cancer treatment, and environmental exposures—rather than a single cause.
- Some people inherit a higher genetic risk for blood cancer, but inheriting the risk does not mean you will definitely develop the disease.
- Exposure to certain chemicals, radiation, or viruses can increase blood cancer risk, though most people exposed to these do not develop cancer.
- Many blood cancers have no identifiable cause, and researchers continue to study why some people develop them and others do not.
Genetic Mutations That Start Blood Cancer
Blood cancer begins with one or more genetic mutations—changes in the DNA of a single cell. These mutations are not inherited from your parents; they happen randomly in that one cell during your lifetime. The mutation might disable a gene that normally stops cells from dividing, or it might activate a gene that pushes cells to divide faster. Once the mutation occurs, the cell divides, and both daughter cells carry the same mutation. After many rounds of division, a large population of identical mutated cells accumulates.
Scientists have identified specific mutations associated with different blood cancers. In chronic myeloid leukemia, for example, a mutation creates an abnormal protein called BCR-ABL that drives cell division. In acute lymphoblastic leukemia, different mutations are common. The specific mutations present determine which type of blood cancer develops and, increasingly, which treatments are most likely to work. This is why doctors test blood cancer cells for mutations—the results guide treatment decisions.
A cell usually needs more than one mutation to become cancerous. It might acquire one mutation that allows it to divide more often, then later acquire another that prevents it from dying when it should. This multi-step process is why blood cancer typically develops over months or years, not overnight.
Age and Blood Cancer Risk
Age is one of the strongest risk factors for blood cancer. The risk rises steadily as you get older, particularly after age 55. This pattern reflects the fact that mutations accumulate over a lifetime—the longer you live, the more chances your cells have to acquire the mutations needed for cancer to develop. Acute myeloid leukemia, for instance, has a median age at diagnosis around 68 years. Lymphoma risk also increases with age, though some types of lymphoma can occur at any age.
Children can develop blood cancer too, but the types differ from those in adults. Acute lymphoblastic leukemia is the most common childhood cancer. The reasons some children develop blood cancer remain poorly understood—age alone cannot explain it, since childhood leukemia is rare despite children having decades of life ahead. Researchers suspect that certain children may inherit a genetic predisposition, or that a specific mutation occurs very early in development.
Inherited Genetic Conditions and Family History
Some people inherit genetic conditions that increase their blood cancer risk. Familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer, and Li-Fraumeni syndrome all raise the likelihood of developing blood cancer, though most people with these conditions never do. If blood cancer runs in your family, your risk is higher than average, but higher risk is not the same as certainty.
Inherited conditions account for only a small fraction of blood cancers overall. Most people who develop blood cancer have no family history of it. If you have a family member with blood cancer, talking with a genetic counselor can help you understand your own risk and whether genetic testing makes sense for you. A counselor can also explain what screening or monitoring might be recommended.
Prior Cancer Treatment and Radiation Exposure
Chemotherapy and radiation used to treat other cancers can increase the risk of developing blood cancer years later. This is called therapy-related blood cancer or secondary blood cancer. The risk depends on the type and dose of treatment received. For example, some chemotherapy drugs used for breast cancer or lymphoma carry a higher risk than others. Radiation to the chest or abdomen also raises risk. These secondary cancers typically develop 5 to 10 years after the original treatment, though the timeline varies.
The risk of developing a secondary blood cancer is real but relatively small—most people who receive chemotherapy or radiation do not develop blood cancer. Doctors weigh this risk against the benefit of treating the original cancer. If you have received chemotherapy or radiation in the past, your doctor may recommend periodic blood tests to watch for early signs of blood cancer.
Accidental or occupational radiation exposure can also increase blood cancer risk. People exposed to high doses of radiation—such as survivors of nuclear accidents or workers in certain industries—have higher rates of blood cancer than the general population. Lower-dose exposures from medical imaging are not believed to significantly raise risk.
Chemical and Environmental Exposures
Benzene, a chemical used in manufacturing and found in gasoline, is a known blood cancer risk factor. Workers in oil refineries, chemical plants, or shoe factories who were exposed to high benzene levels have elevated blood cancer rates. The risk increases with the amount and duration of exposure. Benzene exposure from everyday sources like small amounts in gasoline or consumer products is not believed to cause significant risk.
Pesticides and herbicides have been studied as potential blood cancer risk factors, with mixed results. Some studies suggest a link, particularly for farmers and agricultural workers with long-term exposure, while others find no clear connection. The evidence is not yet strong enough to say definitively that these chemicals cause blood cancer in the general population.
Smoking has been linked to a modest increase in blood cancer risk, particularly acute myeloid leukemia. The risk rises with the number of years smoked and the number of cigarettes per day. Secondhand smoke exposure has not been clearly linked to blood cancer risk.
Viral Infections and Immune System Factors
Certain viruses increase blood cancer risk. Human T-lymphotropic virus type 1 (HTLV-1) causes a rare type of leukemia in a small percentage of infected people, primarily in Japan, the Caribbean, and parts of Africa. Epstein-Barr virus (EBV) is associated with some types of lymphoma, particularly in people with weakened immune systems. Human immunodeficiency virus (HIV) raises the risk of certain lymphomas, though modern HIV treatment has reduced this risk substantially.
A weakened immune system from any cause—whether from HIV, organ transplant medications, or autoimmune disease treatment—increases blood cancer risk. The immune system normally catches and destroys abnormal cells before they multiply. When the immune system is not functioning well, abnormal cells have a better chance of surviving and growing into cancer.
Frequently Asked Questions
Can blood cancer be inherited?
You cannot inherit blood cancer itself, but you can inherit a genetic condition that raises your risk of developing it. Most blood cancers develop from mutations that occur randomly during your lifetime, not from inherited genes. If multiple family members have had blood cancer, genetic counseling can help clarify your personal risk.
Does stress cause blood cancer?
There is no scientific evidence that stress causes blood cancer. While chronic stress can affect immune function, researchers have not found a direct link between stress and blood cancer development. Many other factors—age, genetic mutations, and environmental exposures—play a much larger role.
What is the difference between inherited mutations and acquired mutations?
Inherited mutations are present in every cell of your body from birth and are passed down from your parents. Acquired mutations develop randomly in a single cell during your lifetime and are not passed to your children. Blood cancer develops from acquired mutations in bone marrow cells, though inherited genetic conditions can increase your risk of acquiring those mutations.
If my parent had blood cancer, will I definitely develop it?
No. Having a parent with blood cancer increases your risk above average, but most people with a family history of blood cancer never develop it themselves. Your age, overall health, and exposure to other risk factors all play a role. A genetic counselor can help you understand your specific risk based on your family history.
Can diet or supplements prevent blood cancer?
There is no diet or supplement proven to prevent blood cancer. A healthy diet and regular exercise support overall health and may reduce risk for some cancers, but they cannot eliminate the genetic and environmental factors that lead to blood cancer. If you are concerned about your risk, talk with your doctor about screening or monitoring options.